165 related articles for article (PubMed ID: 34516577)
21. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities.
Valdez CN; Sánchez-Zuno GA; Bucala R; Tran TT
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732068
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
23. MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma.
Bell JB; Eckerdt FD; Alley K; Magnusson LP; Hussain H; Bi Y; Arslan AD; Clymer J; Alvarez AA; Goldman S; Cheng SY; Nakano I; Horbinski C; Davuluri RV; James CD; Platanias LC
Mol Cancer Res; 2016 Oct; 14(10):984-993. PubMed ID: 27364770
[TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
25. Characterization of structurally distinct, isoform-selective phosphoinositide 3'-kinase inhibitors in combination with radiation in the treatment of glioblastoma.
Chen JS; Zhou LJ; Entin-Meer M; Yang X; Donker M; Knight ZA; Weiss W; Shokat KM; Haas-Kogan D; Stokoe D
Mol Cancer Ther; 2008 Apr; 7(4):841-50. PubMed ID: 18413797
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Otvos B; Silver DJ; Mulkearns-Hubert EE; Alvarado AG; Turaga SM; Sorensen MD; Rayman P; Flavahan WA; Hale JS; Stoltz K; Sinyuk M; Wu Q; Jarrar A; Kim SH; Fox PL; Nakano I; Rich JN; Ransohoff RM; Finke J; Kristensen BW; Vogelbaum MA; Lathia JD
Stem Cells; 2016 Aug; 34(8):2026-39. PubMed ID: 27145382
[TBL] [Abstract][Full Text] [Related]
27. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
28. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
[TBL] [Abstract][Full Text] [Related]
30. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
31. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
32. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
33. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.
Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ
FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026
[TBL] [Abstract][Full Text] [Related]
34. Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
Caltabiano R; De Pasquale R; Piombino E; Campo G; Nicoletti F; Cavalli E; Mangano K; Fagone P
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401503
[TBL] [Abstract][Full Text] [Related]
35. Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Thomas JG; Parker Kerrigan BC; Hossain A; Gumin J; Shinojima N; Nwajei F; Ezhilarasan R; Love P; Sulman EP; Lang FF
J Neurosurg; 2018 Jan; 128(1):287-295. PubMed ID: 28362237
[TBL] [Abstract][Full Text] [Related]
36. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
[TBL] [Abstract][Full Text] [Related]
37. Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma.
Sakamoto D; Takagi T; Fujita M; Omura S; Yoshida Y; Iida T; Yoshimura S
Anticancer Res; 2019 Feb; 39(2):597-607. PubMed ID: 30711935
[TBL] [Abstract][Full Text] [Related]
38. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
[TBL] [Abstract][Full Text] [Related]
39. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
40. Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
Põlajeva J; Bergström T; Edqvist PH; Lundequist A; Sjösten A; Nilsson G; Smits A; Bergqvist M; Pontén F; Westermark B; Pejler G; Forsberg Nilsson K; Tchougounova E
Mol Oncol; 2014 Feb; 8(1):50-8. PubMed ID: 24091309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
